Schernthaner GH - Search Results

1

Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site.

Hadzijusufovic E, Albrecht-Schgoer K, Huber K, Hoermann G, Grebien F, Eisenwort G, Schgoer W, Herndlhofer S, Kaun C, Theurl M, Sperr WR, Rix U, Sadovnik I, Jilma B, Schernthaner GH, Wojta J, Wolf D, Superti-Furga G, Kirchmair R, Valent P. Hadzijusufovic E, et al. Among authors: schernthaner gh. Leukemia. 2017 Nov;31(11):2388-2397. doi: 10.1038/leu.2017.245. Epub 2017 Jul 31. Leukemia. 2017. PMID: 28757617 Free PMC article.

2

Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors.

Valent P, Hadzijusufovic E, Schernthaner GH, Wolf D, Rea D, le Coutre P. Valent P, et al. Among authors: schernthaner gh. Blood. 2015 Feb 5;125(6):901-6. doi: 10.1182/blood-2014-09-594432. Epub 2014 Dec 18. Blood. 2015. PMID: 25525119 Free article.

3

Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML.

Valent P, Hadzijusufovic E, Hoermann G, Füreder W, Schernthaner GH, Sperr WR, Kirchmair R, Wolf D. Valent P, et al. Among authors: schernthaner gh. Leuk Res. 2017 Aug;59:47-54. doi: 10.1016/j.leukres.2017.05.008. Epub 2017 May 12. Leuk Res. 2017. PMID: 28549238 Free PMC article. Review.

4

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

Florian S, Sonneck K, Hauswirth AW, Krauth MT, Schernthaner GH, Sperr WR, Valent P. Florian S, et al. Among authors: schernthaner gh. Leuk Lymphoma. 2006 Feb;47(2):207-22. doi: 10.1080/10428190500272507. Leuk Lymphoma. 2006. PMID: 16321850

5

Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML.

Aichberger KJ, Herndlhofer S, Schernthaner GH, Schillinger M, Mitterbauer-Hohendanner G, Sillaber C, Valent P. Aichberger KJ, et al. Among authors: schernthaner gh. Am J Hematol. 2011 Jul;86(7):533-9. doi: 10.1002/ajh.22037. Epub 2011 Apr 27. Am J Hematol. 2011. PMID: 21538470 Free article. Clinical Trial.

6

Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.

Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny HP, Valent P. Sperr WR, et al. Among authors: schernthaner gh. Leuk Res. 2001 Jul;25(7):529-36. doi: 10.1016/s0145-2126(01)00041-8. Leuk Res. 2001. PMID: 11377677

7

A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.

Jordan JH, Fritsche-Polanz R, Sperr WR, Mitterbauer G, Födinger M, Schernthaner GH, Christian Bankl H, Gebhart W, Chott A, Lechner K, Valent P. Jordan JH, et al. Among authors: schernthaner gh. Leuk Res. 2001 Jul;25(7):627-34. doi: 10.1016/s0145-2126(01)00019-4. Leuk Res. 2001. PMID: 11377687

8

A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy.

Hauswirth AW, Sperr WR, Ghannadan M, Schernthaner GH, Jordan JH, Fritsche-Polanz R, Simonitsch-Klupp I, Födinger M, Lechner K, Valent P. Hauswirth AW, et al. Among authors: schernthaner gh. Leuk Res. 2002 Jun;26(6):601-6. doi: 10.1016/s0145-2126(01)00172-2. Leuk Res. 2002. PMID: 12007509

9

Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria.

Jordan JH, Schernthaner GH, Fritsche-Polanz R, Sperr WR, Födinger M, Chott A, Geissler K, Lechner K, Horny HP, Valent P. Jordan JH, et al. Among authors: schernthaner gh. Leuk Lymphoma. 2002 Mar;43(3):575-82. doi: 10.1080/10428190290012065. Leuk Lymphoma. 2002. PMID: 12002761

10

Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.

Schernthaner GH, Spanblöchl E, Sperr WR, Sillaber C, Semper H, Jurecka W, Hagen W, Wolff K, Chott A, Lechner K, Valent P. Schernthaner GH, et al. Ann Hematol. 2000 Dec;79(12):660-6. doi: 10.1007/s002770000206. Ann Hematol. 2000. PMID: 11195002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters